The healthcare sector, the third-largest sector weight in the S&P 500, is the midst of a stunning first-to-worst act. What was once the best-performing sector in the S&P 500 is seeing those gains rapidly evaporate, led by a severe repudiation of biotechnology stocks and exchange traded funds.
In what would have been an unthinkable statistic a few months ago, seven of the 11 worst-performing ETFs, including the five worst, over the past five days are healthcare funds. Cementing the cruelty currently being faced by healthcare ETFs, the only ETFs that made new highs on Monday were two inverse biotech funds.
Investors with the temerity to search for a potential healthcare rebound candidate might want to have a look at the $253.1 million PowerShares S&P SmallCap ...
/www.benzinga.com/general/biotech/15/09/5871030/small-cap-healthcare-etf-a-baby-thrown-out-with-the-bathwater alt=Small-Cap Healthcare ETF: A Baby Thrown Out With The Bathwater>Full story available on Benzinga.com
More...